Narrative review / 2014
Genistein targets pathways of prostate cancer detachment, invasion, and metastasis at concentrations attainable via diet.
This review examines preclinical and clinical evidence on genistein, a compound found in high amounts in soy, in preventing prostate cancer metastasis. In vitro, rodent models, and prospective human clinical trials support genistein as an antimetastatic agent that inhibits cell detachment, protease production, and invasion at dietary concentrations. Phase I and phase II trials showed that concentrations associated with antimetastatic efficacy in models are achievable in humans and that genistein inhibits pathways regulating metastatic transformation in human prostate tissue.
- Study type
- Narrative review
- Who was studied
- Men with or at risk for prostate cancer, along with preclinical models
- What was measured
- Prostate cancer metastasis, cell detachment, invasion, and metastatic pathway regulation
THE PAPER
Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis.
Pavese JM, Krishna SN, Bergan RC. Am J Clin Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.